Abstract: The present disclosure provides a technology capable of favorably using a vehicle driven by a driver or an autonomous vehicle as a delivery vehicle to deliver goods. An information processing apparatus includes a controller including at least one processor configured to execute assigning either a first vehicle that is a vehicle driven by a driver or a second vehicle that is an autonomous vehicle as a delivery vehicle to deliver goods to a user. When a predetermined event other than the delivery of the goods to the user is requested to be performed at a delivery destination, the controller selects the first vehicle as the delivery vehicle.

Abstract: An information processing apparatus includes a controller, the controller being configured to select a first mobile body to deliver baggage to a delivery destination existing in a predetermined facility from among a plurality of types of delivery mobile bodies, wherein the controller selects the first mobile body, based on required time necessary to deliver the baggage to the delivery destination in a site of the predetermined facility, for each delivery mobile body.

Abstract: An information processing device determines, based on location information of a plurality of delivery destinations for package delivery: one or a plurality of first delivery destinations for package delivery by a vehicle; and one or a plurality of second delivery destinations for package delivery by a drone mounted on the vehicle. In addition, the information processing device determines: a travel route including a route for the vehicle to perform package delivery to the one or plurality of first delivery destinations; a first point on the travel route for the drone to start flying from the vehicle to the one or plurality of second delivery destinations; and a second point on the travel route for the drone to return to the vehicle.

Abstract: The present invention provides a method for producing megakaryocytes that have an increased capacity to produce platelets, the method comprising a step of culturing, under conditions that cause the death of cells that do not express a gene that is specifically expressed by megakaryocytes, cells that have the capacity to differentiate into megakaryocytes.

Abstract: The present invention provides a highly functional platelet production promoting agent which comprises one or a plurality of aryl hydrocarbon receptor (AhR) antagonists and one or a plurality of Rho-associated coiled-coil forming kinase (ROCK) inhibitors.

Abstract: The present invention provides a highly functional platelet production promoting agent which comprises one or a plurality of aryl hydrocarbon receptor (AhR) antagonists and one or a plurality of Rho-associated coiled-coil forming kinase (ROCK) inhibitors.

Abstract: The present invention provides a method for producing megakaryocytes that have an increased capacity to produce platelets, the method comprising a step of culturing, under conditions that cause the death of cells that do not express a gene that is specifically expressed by megakaryocytes, cells that have the capacity to differentiate into megakaryocytes.